DeutschNewstral
Article
The Times of India on 2024-05-20 08:19
'Poorly designed': ICMR distances itself from BHU's Covaxin study
Related news
ICMR distances itself from study claiming India's COVID-19 peak in mid-NovemberThe Hindu- Better protection with Covishield-Covaxin combination: ICMRThe Hindu
- Covaxin effective against Delta Plus variant: ICMRThe Times of India
- ICMR slams BHU's Covaxin study, says it wasn't part of itThe Times of India
- Study on Covaxin, Covishield mix shows better results, ICMR saysThe Times of India
- Delta variants lineages reduces Covaxin antibodies, ICMR studyThe Hindu
- Covishield-Covaxin mix offers better shield, says ICMR studyThe Times of India
- Mixing Covaxin and Covishield is safe and effective: ICMRThe Times of India
- Covaxin development has proved India is more than pharmacy of world: ICMR chiefThe Hindu
- COVID-19 | Covaxin booster dose enhances vaccine effectiveness against Delta, Omicron variants, says ICMR studyThe Hindu
- ICMR to get royalty from Covaxin saleThe Hindu
- Govt distances itself from Swamy's remarkThe Times of India
- Mix and match of Covishield and Covaxin safe, more effective: ICMR studyThe Times of India
Facebook Distances Itself From Marc Andreessen’s Statements On Free BasicsTechCrunch- India distances itself from Pak move on JadhavThe Times of India
- U.S. distances itself from Trump attempts to ban WeChatThe Hindu
- RSS distances itself from Panchjanya article on InfosysThe Hindu
- MSport24.co.za | CSA distances itself from Smith's Ganguly backingm.sport24.co.za
- BJP slams Pitroda, Cong distances itself from 'skin colour' remarkThe Times of India
- Australia recognises CovaxinThe Times of India